Calton & Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-15,503
| Closed | -$802K | – | 199 |
|
|
2024
Q3 | $802K | Buy |
15,503
+5,711
| +58% | +$296K | 0.31% | 77 |
|
|
2024
Q2 | $407K | Sell |
9,792
-994
| -9% | -$41.3K | 0.2% | 108 |
|
|
2024
Q1 | $585K | Buy |
+10,786
| New | +$585K | 0.29% | 83 |
|
|
2023
Q1 | – | Sell |
-2,865
| Closed | -$206K | – | 243 |
|
|
2022
Q4 | $206K | Buy |
+2,865
| New | +$206K | 0.08% | 257 |
|
|
2022
Q1 | – | Sell |
-4,145
| Closed | -$258K | – | 361 |
|
|
2021
Q4 | $258K | Sell |
4,145
-1,882
| -31% | -$117K | 0.07% | 298 |
|
|
2021
Q3 | $356K | Sell |
6,027
-551
| -8% | -$32.5K | 0.08% | 253 |
|
|
2021
Q2 | $439K | Buy |
6,578
+96
| +1% | +$6.41K | 0.08% | 218 |
|
|
2021
Q1 | $409K | Sell |
6,482
-1,989
| -23% | -$126K | 0.08% | 223 |
|
|
2020
Q4 | $525K | Sell |
8,471
-1,743
| -17% | -$108K | 0.09% | 174 |
|
|
2020
Q3 | $616K | Sell |
10,214
-1,249
| -11% | -$75.3K | 0.13% | 136 |
|
|
2020
Q2 | $674K | Buy |
11,463
+756
| +7% | +$44.5K | 0.15% | 114 |
|
|
2020
Q1 | $597K | Sell |
10,707
-2,225
| -17% | -$124K | 0.15% | 123 |
|
|
2019
Q4 | $830K | Buy |
12,932
+4,923
| +61% | +$316K | 0.17% | 116 |
|
|
2019
Q3 | $406K | Sell |
8,009
-550
| -6% | -$27.9K | 0.09% | 184 |
|
|
2019
Q2 | $388K | Buy |
8,559
+68
| +0.8% | +$3.08K | 0.11% | 158 |
|
|
2019
Q1 | $405K | Sell |
8,491
-1,180
| -12% | -$56.3K | 0.12% | 152 |
|
|
2018
Q4 | $503K | Buy |
9,671
+1,224
| +14% | +$63.7K | 0.19% | 109 |
|
|
2018
Q3 | $524K | Sell |
8,447
-2,733
| -24% | -$170K | 0.15% | 114 |
|
|
2018
Q2 | $673K | Sell |
11,180
-6,331
| -36% | -$381K | 0.2% | 88 |
|
|
2018
Q1 | $1.11M | Buy |
17,511
+967
| +6% | +$61.2K | 0.32% | 62 |
|
|
2017
Q4 | $1.05M | Buy |
+16,544
| New | +$1.05M | 0.26% | 67 |
|